L-Tyrosine Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about L-Tyrosine dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for L-Tyrosine.
Dosing Protocols
A defensible beginner L-tyrosine protocol starts with understanding that tyrosine is primarily a situational cognitive enhancer — it matters most under stress conditions and matters less in rested, unstressed states. Beginners should plan to test tyrosine in a context where they expect meaningful cognitive stress (a demanding work day, a period of sleep restriction, a cognitively challenging event) rather than in a neutral low-stress testing period. Sourcing: L-tyrosine is widely available as a dietary supplement in the US and most countries. Reputable supplement manufacturers (NOW Foods, Pure Encapsulations, Jarrow, BulkSupplements, Nutricost) provide pharmaceutical-grade L-tyrosine at reasonable prices. Look for products with third-party testing (NSF, USP, or Informed Choice certification) and listed specifications. Capsules of 500 mg or 1000 mg are the most common commercial format; bulk powder is less expensive and allows dose flexibility but is inconvenient for on-demand use. Plain L-tyrosine is preferred over N-acetyl-L-tyrosine (NALT) based on pharmacokinetic evidence that plain L-tyrosine delivers more tyrosine to tissues per gram dosed. Beginner dose: 500-1000 mg taken on an empty stomach (or with a small carbohydrate-only snack) 30-60 minutes before an anticipated cognitive stress. Common protocol: 500 mg in the morning 30-60 minutes before starting work or a demanding task, with option to repeat 500 mg in early afternoon if stress continues. Maximum beginner dose: 2000 mg total in a day. Taking tyrosine with a protein-heavy meal reduces brain tyrosine delivery due to LAT1 transport competition — avoid taking with protein shakes, high-protein meals, or large quantities of meat/dairy/eggs. Taking with coffee, plain water, or fruit (carbohydrate) is fine. Timing is important. Morning or early afternoon dosing aligns with the typical peak-workload portion of the day. Late afternoon and evening dosing can produce sleep disruption and should be avoided in users sensitive to sleep effects. The effect onset is 30-60 minutes and peaks at 1-2 hours, with cognitive benefits persisting 3-6 hours. Trial duration: beginners should test tyrosine on 5-10 demanding days over a 2-4 week period to characterize their response. Test questions: during the stress period, did you notice improved cognitive function (subjectively, on specific tasks, in mood/motivation)? Were side effects tolerable? Would you continue taking tyrosine under similar future conditions? Side effect monitoring for beginners: GI effects (usually resolve with small carbohydrate intake), mild headache (usually resolves), sleep effects (avoid late-day dosing), cardiovascular effects (in users with risk factors, monitor BP and pulse with the first several doses). Decision framework after the trial period: clear cognitive benefit without significant side effects → continue using tyrosine for similar future stress situations; ambiguous response → try higher dose (1500-2000 mg) before concluding; clear negative response or significant side effects → discontinue. Chronic daily use vs. on-demand use: for most users, on-demand use (taking tyrosine specifically before anticipated stress) is preferred over chronic daily supplementation. Chronic use produces partial physiologic adaptation that may reduce the acute cognitive effect during stress. Some users with chronic cognitive demands (sustained shift work, ongoing high-stress work) adopt daily supplementation, but cycling (using tyrosine during high-demand periods, stopping during recovery periods) preserves the effect better than continuous chronic use. Beginners should resist the common supplement pattern of "take it every day indefinitely" — tyrosine works best when used with intention for specific purposes.
Intermediate L-tyrosine users have established personal response through a testing period and are using tyrosine strategically for cognitive performance in specific situations. Intermediate dosing typically falls in the 1000-2000 mg range per dose, with 1-2 doses per day during cognitively demanding periods. Total daily intake in active use is 1000-4000 mg depending on the duration and intensity of cognitive demand. Intermediate users have typically optimized several aspects: timing (morning and/or early afternoon dosing tied to expected cognitive peak times); dose (personal effective dose determined through experimentation); food interactions (fasted or carb-only administration for optimal BBB transport); cycling (on-demand use tied to stress periods rather than chronic daily use); and stack context (using tyrosine as part of a broader performance approach rather than as a solo intervention). Common intermediate stacks: tyrosine 1000-1500 mg + caffeine 200 mg + L-Theanine 200 mg for focused productivity; tyrosine + Modafinil for extended cognitive work days; tyrosine + Piracetam 2.4-4.8 g + alpha-GPC 300 mg for broad cognitive support; tyrosine + Sulbutiamine 400-600 mg for motivation-depressive symptoms. These combinations are situation-dependent rather than daily standards. At the intermediate level, users recognize specific use cases: exam preparation (load tyrosine before study sessions); high-stakes presentations or meetings (dose 60-90 minutes before); sustained work periods (repeated dosing with spacing); jet lag recovery (support catecholamine function during circadian disruption); sleep-deprived performance (dose strategically during anticipated cognitive demands on limited sleep); cold weather outdoor work (dose before cold exposure); athletic competition involving cognitive decision-making (dose before competition). Monitoring at the intermediate level: track cognitive outcomes in high-stake situations (did tyrosine help? how much?); monitor blood pressure trends for users with cardiovascular risk factors; periodic thyroid function testing (TSH, free T4) for chronic users; attention to sleep quality on days when tyrosine is used. Dose-response consideration: higher doses do not linearly increase cognitive benefits, and users commonly find a personal sweet spot (often 1000-1500 mg) beyond which additional tyrosine produces more side effects without more benefits. Intermediate users respect this relationship and do not chase higher doses. Cycling vs. chronic use: intermediate users commonly adopt one of two approaches. On-demand cycling: tyrosine used specifically before anticipated stress, with many days of non-use between applications. This approach preserves the pharmacologic effect and minimizes any adaptation. Chronic daily use: tyrosine taken daily at 1000-2000 mg for users with continuous cognitive demands. This approach may produce some reduction in acute effect magnitude but provides baseline catecholamine support. Hybrid: daily baseline dose with acute higher dose before specific stress. Intermediate users choose based on their personal demand pattern and response. Drug interactions at the intermediate level: coordination with any prescribed medications. Particular attention to thyroid medications, cardiovascular medications, and psychotropic drugs. Absolute avoidance of MAO inhibitor combinations. Monitoring for any new medications that might interact. The intermediate user develops a mental model of when tyrosine is worth using — the specific cognitive demands, stress profiles, and situations where tyrosine has demonstrated personal benefit — and uses it selectively for those conditions rather than as a generic daily supplement. This selectivity maximizes the value of the supplement and minimizes exposure during periods when it adds nothing.
Advanced L-tyrosine users integrate the supplement into sophisticated cognitive performance and health optimization frameworks with sophisticated understanding of when tyrosine helps, when it does not, and how to maximize its effectiveness. Advanced dosing uses the 1000-3000 mg range per dose with strategic timing tied to specific cognitive demands. Total daily intake during active use periods may reach 4000-6000 mg in divided doses. Higher doses (research-scale 7-12 g per dose) are used occasionally by advanced users for extreme cognitive challenges (major examinations, high-stakes competitions, sustained operational demands) but require careful attention to tolerance, hydration, and cardiovascular status. Advanced stacks integrate tyrosine into comprehensive cognitive enhancement frameworks. A representative advanced cognitive performance protocol might include: tyrosine 1500-2000 mg morning + 1000-1500 mg early afternoon (on demanding days); Modafinil 100-200 mg morning; L-Theanine 200 mg with morning dose; caffeine 200-400 mg distributed through morning/midday; alpha-GPC 300-600 mg daily; Noopept 20-30 mg daily; Piracetam 4.8 g daily split 3x; Sulbutiamine 400-600 mg 3-5 days/week; Lion's Mane 1000 mg daily; Uridine Monophosphate 150-300 mg daily; Methylene Blue 0.5-2 mg/kg daily; NAD+ precursors 500-1000 mg daily; omega-3 fatty acids 2-3 g daily; vitamin D, B-complex, magnesium as indicated; and baseline medications as individually needed. This comprehensive stack represents high nootropic sophistication and introduces all the attribution-loss concerns of complex regimens. Advanced users use tyrosine strategically within the broader stack: baseline daily maintenance at moderate dose (1000-1500 mg) with acute loading (additional 1000-2000 mg) before specific high-demand events. Some advanced users pair tyrosine with training and exercise protocols. High-intensity exercise can acutely deplete catecholamines, and pre-workout tyrosine may support sustained cognitive function and mood during demanding training sessions. Evidence for specific athletic performance benefits of tyrosine is mixed, but cognitive components of performance (decision-making under fatigue, mental toughness during prolonged exercise) may benefit. Cold exposure protocols (deliberate cold immersion, cold shower practices, winter outdoor training) are a specific application where tyrosine has strong research support. Advanced cold-exposure users dose tyrosine 500-1500 mg approximately 60 minutes before cold exposure to support catecholaminergic function during the stress response. Sleep deprivation scenarios (on-call medical work, long-haul transportation operation, extended research or creative projects) are another well-supported tyrosine application. Dose strategically during the sleep-deprived period (500-1000 mg every 4-6 hours during active cognitive work) to support catecholamine function that is under chronic demand. Monitoring at the advanced level: comprehensive annual labs including thyroid function (TSH, free T4, free T3, TPO antibodies), cardiovascular markers (BP trends, ECG if indicated, lipid panel), liver function, kidney function, hormone panel, and nutritional markers. Subjective cognitive performance tracking: standardized self-assessments of cognitive performance at key time points, task-specific performance metrics (reaction time tests, working memory tests, processing speed tests), and outcome tracking for major cognitive events (exam scores, work productivity measures, competitive performance). Cardiovascular monitoring: BP and HR trends with tyrosine dosing, particularly in users over 40 or with cardiovascular risk factors. Advanced users should also maintain awareness of tyrosine's specific contraindications — MAO inhibitors (absolute avoidance), active melanoma (avoid high-dose chronic use), hyperthyroidism (coordinate with endocrinology), and L-DOPA interactions for PD patients. Protocol exit and de-escalation: chronic tyrosine supplementation does not need to be lifelong. Users whose cognitive demands have changed (career transitions, retirement, reduced stress) should consider de-escalating to purely on-demand use or discontinuation. Users who have addressed underlying factors (sleep optimization, stress management, lifestyle changes) may find tyrosine less necessary than before. Advanced users apply the same discipline to discontinuation that they applied to use — tracking outcomes with and without the compound and making evidence-based decisions about whether continued use remains justified. The overall theme at the advanced level is that tyrosine is a valuable but specific tool for cognitive performance under stress, not a general cognitive enhancer for rested high-functioning users, and the sophistication of use should match the sophistication of understanding.
Commonly Stacked With
L-Tyrosine stacks commonly with other cognitive enhancement and performance compounds, typically as an acute pre-stress loading dose or as a chronic catecholaminergic support in comprehensive nootropic stacks. The most common and mechanistically coherent combination is with caffeine. Caffeine at 100-300 mg combined with L-tyrosine 500-2000 mg taken 30-60 minutes before cognitively demanding work is a well-tested performance stack — caffeine provides acute adenosine antagonism and alertness while tyrosine supports catecholamine synthesis for sustained cognitive function. Military research has extensively examined this combination in operational scenarios. With Modafinil, the combination provides catecholamine precursor support for modafinil's dopaminergic and noradrenergic effects. Users often report that tyrosine reduces the modest fatigue that can occur as modafinil's effects begin to wane, extending the functional effect duration. Dose tyrosine 500-2000 mg with or shortly after the modafinil dose. Evidence for synergy is primarily anecdotal but mechanism is coherent. With Piracetam and other racetams, the combination adds catecholamine support to piracetam's broader cognitive modulation. Useful particularly in users whose baseline catecholamine tone is low or during stress. With Noopept, the combination pairs noopept's memory and BDNF effects with tyrosine's catecholamine precursor support. With Sulbutiamine, the combination compounds dopaminergic effects — sulbutiamine modestly enhances dopaminergic function, and tyrosine provides substrate for dopamine synthesis. Useful in users with low-energy depression or asthenia. With L-Theanine, the combination balances tyrosine's activating effects with theanine's calm focus, producing focused alertness without jitteriness. Popular in productivity-oriented stacks. Coffee/caffeine + L-theanine 100-200 mg + L-tyrosine 500-1000 mg is a well-known morning productivity formula. With Bromantane, the Russian actoprotector, the combination provides multiple layers of catecholaminergic support — bromantane upregulates tyrosine hydroxylase expression while tyrosine provides substrate, potentially producing more sustained effects than either alone. With Selank and Semax, the Russian peptides, combinations pair tyrosine's catecholamine support with the peptides' anxiolytic and neurotrophic effects. With Lion's Mane, the combination pairs acute catecholamine support with potential neurotrophic effects from NGF/BDNF stimulation. No mechanism conflict. With Uridine Monophosphate, the Wurtman-stack component for phosphatidylcholine and dopaminergic membrane support, the combination provides broader neurotransmitter system support. With Methylene Blue, the combination provides catecholamine support with mitochondrial electron transport enhancement — mechanistically unrelated but complementary for cognitive performance. With NAD+ precursors (NR, NMN), the combination adds cellular energy support to catecholamine precursor support. With amphetamine-class stimulants (Adderall, Dexedrine), theoretical rationale exists for tyrosine supporting sustained catecholamine synthesis during amphetamine-induced release, but the combination can also produce additive anxiety and cardiovascular effects. Users on prescription amphetamines should discuss tyrosine with their prescriber before adding it. With methylphenidate (Ritalin, Concerta), similar considerations apply. With SSRIs and SNRIs, tyrosine is generally considered compatible — the serotonergic effects of these medications are unrelated to catecholamine precursor status. Some depression stack designers use tyrosine as adjunctive support for the dopaminergic or noradrenergic symptoms of depression not fully addressed by serotonergic antidepressants alone. MAO inhibitors are the major combination to AVOID — as noted in the side effects section, tyrosine with MAOIs can produce dangerous catecholamine elevations. With thyroid hormone replacement, tyrosine use is compatible but may require thyroid function monitoring. With L-DOPA in Parkinson's disease, timing considerations apply to avoid LAT1 transport competition. For pre-workout and athletic performance, tyrosine is commonly combined with caffeine, beta-alanine, creatine, citrulline, and other ergogenic compounds. Evidence for specific athletic performance benefits of tyrosine (as distinct from cognitive performance during sustained exercise) is mixed, with stronger support for vigilance and decision-making under exercise stress than for pure strength or endurance outcomes. With GH secretagogues (CJC-1295, Ipamorelin), no mechanism conflict. With weight loss compounds (Semaglutide, Tirzepatide), tyrosine may provide cognitive performance support during the caloric restriction associated with GLP-1 therapy. With Methylene Blue, compatible. With nicotine, tyrosine's catecholamine support may enhance nicotine's cognitive effects; theoretical rationale is modest. Stacking fundamentals: tyrosine's effect is modest and situation-dependent (helps under stress, less effect when rested), so piling multiple other compounds on top may not increase effects proportionally. Users should test tyrosine alone first to characterize their personal response before incorporating it into complex stacks. Tyrosine's on-demand use (taken specifically before anticipated stress rather than chronically) is often more effective than chronic daily supplementation.
Side Effects & Safety
Contraindications
L-Tyrosine has a favorable contraindication profile reflecting its status as a normal dietary amino acid. Absolute contraindications are few: concurrent MAO inhibitor therapy (phenelzine, tranylcypromine, isocarboxazid, moclobemide, and similar) or recent MAO inhibitor discontinuation (within 2 weeks) — this combination can produce dangerous catecholamine elevations with risk of hypertensive crisis, cardiac arrhythmias, or sympathomimetic toxicity; known hypersensitivity to L-tyrosine or supplement components. Significant contraindications: active melanoma or recent melanoma treatment — the theoretical concern about tyrosine-supporting melanin synthesis via tyrosinase, while not extensively documented in clinical studies, is sufficient basis to avoid high-dose chronic tyrosine in patients with active melanoma. Patients with strong personal or family history of melanoma should consult their oncologist or dermatologist before starting L-tyrosine supplementation. Hyperthyroidism and Graves' disease: tyrosine is a substrate for thyroid hormone synthesis, and chronic supplementation could theoretically worsen hyperthyroid states. Patients with hyperthyroidism, treated Graves' disease, or thyroid nodules under evaluation should avoid or use L-tyrosine only with endocrinology oversight. Relative contraindications and precautions: hypertension — tyrosine's catecholaminergic effects can modestly increase blood pressure; patients with uncontrolled hypertension should avoid L-tyrosine or use low doses with close BP monitoring; patients with controlled hypertension can usually use L-tyrosine but should monitor BP trends. Cardiovascular disease (recent MI, unstable angina, arrhythmias): similar considerations; use only with cardiology oversight if at all. Parkinson's disease on L-DOPA therapy: tyrosine and L-DOPA compete for BBB LAT1 transport; dosing at different times than L-DOPA (3-4 hours separation) may minimize interference but the combination is generally not ideal. Phenylketonuria (PKU): patients with PKU cannot convert phenylalanine to tyrosine effectively, and supplemental tyrosine is actually part of their medical management rather than a concern — this is an indication rather than a contraindication. Pregnancy: tyrosine is a normal dietary component and supplemental doses within the typical range (500-2000 mg daily) are not expected to cause pregnancy complications. Higher doses have not been extensively studied in pregnancy. Pregnant women should consult their physician before starting L-tyrosine supplementation. Breastfeeding: similar to pregnancy — normal dietary ranges are not concerning; higher doses should be discussed with the physician. Pediatric use: safe in children with PKU at medically directed doses. Cognitive performance supplementation in healthy children should be avoided without specific medical guidance. Psychiatric disorders: bipolar disorder may theoretically be worsened by catecholaminergic activation, though clinically significant effects at typical supplement doses are uncommon. Patients with bipolar disorder should discuss L-tyrosine with their psychiatrist before use. Schizophrenia: dopaminergic activation is generally contraindicated in active psychosis; patients with schizophrenia or schizoaffective disorder should not use L-tyrosine outside of psychiatric supervision. Anxiety disorders: may be worsened by tyrosine's activating effects; users with significant anxiety should test with caution or avoid. Renal impairment: tyrosine is not primarily renally cleared and does not accumulate significantly in renal impairment. Dose adjustment is not typically required but common sense suggests avoiding chronic high doses in advanced kidney disease. Hepatic impairment: tyrosine metabolism is primarily enzymatic at sites of catecholamine synthesis rather than hepatic; significant hepatic impairment does not require dose adjustment. Drug interactions of clinical concern: MAO inhibitors (absolute avoidance — the most important drug interaction); amphetamines and methylphenidate (theoretical additive catecholamine effects; coordinate with prescriber); SSRIs and SNRIs (generally compatible; some stack designers use tyrosine as adjunctive support); L-DOPA (timing separation to avoid LAT1 competition); thyroid hormone replacement (possible modest effects on thyroid requirements over time, monitor TSH); cardiovascular medications (additive blood pressure effects possible in some combinations); other catecholaminergic compounds (additive effects). Compounds that are generally compatible: caffeine, L-theanine, modafinil (with monitoring), piracetam, noopept, sulbutiamine, omega-3 fatty acids, B-complex vitamins, magnesium, most supplements and prescription medications not in the above categories. Absence of clinical oversight is the general consideration. For healthy adults using L-tyrosine within the typical supplement dose range for cognitive performance, formal medical oversight is not strictly required. For users with specific medical conditions, significant medication regimens, or higher doses, medical involvement is appropriate. Users should inform their physicians of L-tyrosine use during routine healthcare encounters to ensure appropriate consideration in clinical decision-making.
Additional Notes
L-Tyrosine is dosed orally as capsules, tablets, or powder. The standard adult cognitive performance dose is 500-2000 mg per dose, taken 30-60 minutes before anticipated cognitive stress or demanding work. Total daily intake in active use typically ranges from 1000-4000 mg in 1-3 divided doses. Higher doses from the original research (7-12 g or 100-150 mg/kg) are used occasionally for extreme cognitive challenges but are not standard for routine cognitive enhancement applications. Beginner dosing: 500-1000 mg per dose, 1-2 times per day on demanding days. Intermediate dosing: 1000-2000 mg per dose, 1-2 times per day. Advanced dosing: 1000-3000 mg per dose, up to 2-3 times per day. Dose timing: morning dosing aligns with natural catecholamine peak and anticipated cognitive demands. Early afternoon second dose can extend the effect through afternoon cognitive work. Late afternoon and evening dosing commonly produces sleep disruption in sensitive users. For specific events, dose 30-60 minutes before the cognitive demand (exam, presentation, competition, demanding work block). Administration conditions: optimal brain tyrosine delivery occurs with fasted-state administration because tyrosine competes with other large neutral amino acids (phenylalanine, tryptophan, leucine, isoleucine, valine) for LAT1 transport at the blood-brain barrier. Taking tyrosine with protein reduces brain tyrosine delivery and dampens the cognitive effect. Practical recommendations: take tyrosine on an empty stomach (ideally 30+ minutes before the next meal), or take with a small carbohydrate snack (banana, fruit, small amount of juice) that does not contain significant protein. Avoid taking with protein shakes, high-protein meals (steak, chicken, fish, eggs), or protein-rich snacks. Water or black coffee with the dose is fine. N-Acetyl-L-Tyrosine (NALT) is commonly marketed as having superior bioavailability but pharmacokinetic studies generally show lower tyrosine delivery from equivalent doses of NALT compared to plain L-tyrosine. Plain L-tyrosine at appropriate doses is the pharmacokinetically preferred form. Some users claim subjective preference for NALT; these claims are not supported by bioavailability data. Onset of effects: 30-60 minutes from oral administration, peak 1-2 hours, duration 3-6 hours. Effects are more pronounced under stress conditions than in rested states. Tolerance and adaptation: chronic daily tyrosine supplementation produces modest adaptation that may reduce acute effect magnitude over time. On-demand use (only when stress is anticipated) preserves the acute effect better than chronic daily dosing. Users adopting chronic daily use should consider periodic cycling or dose holidays. Discontinuation: tyrosine can be stopped without taper at any time without withdrawal effects. Elimination is rapid and no physical dependence occurs. Formulations: plain L-tyrosine USP is the standard form used in research and clinical applications. Pharmaceutical-grade L-tyrosine USP is available from reputable supplement manufacturers. Capsules typically contain 500 mg or 1000 mg per capsule. Tablets are less common. Powder allows dose flexibility but has a bitter taste — can be dissolved in water or added to food, though food addition should avoid protein-rich items. Cost: plain L-tyrosine is inexpensive. Typical US retail prices for pharmaceutical-grade L-tyrosine: $10-25 per 100-gram bottle of powder, or $15-30 per 60-capsule bottle of 1000 mg capsules. Daily supplementation at 2 g costs $0.20-0.50 per day. Quality considerations: look for products with third-party certification (NSF, USP, Informed Choice), certificate of analysis available on request, reasonable price in the normal market range. Avoid dramatically cheap sources that may have purity issues. Storage: L-tyrosine is a stable amino acid and can be stored at room temperature with protection from moisture and light. Refrigeration is not required. Properly stored capsules and powder remain potent for 2-3 years. Signs of degradation (color changes, clumping from moisture absorption, unusual odor) warrant discarding. Dose adjustment considerations: thyroid conditions (hyperthyroidism: avoid or use low doses with monitoring; hypothyroidism on levothyroxine: may affect replacement needs over time, monitor TSH); cardiovascular conditions (start at lower doses, monitor BP and HR); renal impairment (no significant dose adjustment needed because tyrosine is not primarily renally cleared); hepatic impairment (no significant dose adjustment needed); pregnancy and lactation (use within normal dietary ranges, consult physician for higher doses); age (elderly patients may benefit from lower starting doses with titration).
Frequently Asked Questions
What is the recommended L-Tyrosine dosage?
Dosage for L-Tyrosine varies by protocol. Consult a qualified healthcare provider.
How often should I take L-Tyrosine?
Administration frequency depends on the specific protocol. Consult current research literature.
Does L-Tyrosine need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are L-Tyrosine side effects?
L-Tyrosine has a highly favorable safety profile as a non-essential dietary amino acid that is normally consumed in gram quantities daily from food. Supplemental tyrosine at typical cognitive-performance doses of 500-2000 mg (or even the higher research doses of 7-12 g) produces minimal side effects in healthy users. The compound is generally recognized as safe (GRAS) by regulatory agencies and has been used safely in clinical research for decades. Most common side effects, which occur infrequently and are usually mild: gastrointestinal effects including mild nausea, stomach discomfort, or loose stools at higher doses, particularly on an empty stomach where tyrosine is recommended for optimal BBB transport. Taking tyrosine with a small amount of food (a few carbohydrate grams is acceptable and does not meaningfully interfere with transport) can mitigate GI effects for sensitive users. Mild headache occurs in some users, usually at higher doses or with chronic daily use, typically resolving with dose reduction or cycling. Nervousness, jitteriness, or mild anxiety can occur in sensitive users, reflecting the catecholamine-enhancing mechanism. These effects are more pronounced with combination with caffeine, modafinil, or other stimulants and usually respond to dose reduction. Sleep disturbance can occur if tyrosine is taken late in the day. Morning or early afternoon dosing is recommended; afternoon and evening dosing should be avoided in users sensitive to sleep effects. Cardiovascular effects including mild increases in heart rate and blood pressure can occur at higher doses, particularly in combination with other catecholaminergic or stimulant compounds. These effects are generally clinically insignificant in healthy users but warrant caution in users with hypertension, cardiac arrhythmias, or other cardiovascular conditions. Thyroid function effects are an important theoretical consideration. Tyrosine is a substrate for thyroid hormone synthesis, and high-dose chronic tyrosine supplementation could theoretically increase thyroid hormone production in individuals with hyperthyroidism or borderline thyroid function. In practice, this effect is modest for typical supplementation doses (500-2000 mg daily) in healthy users with normal thyroid function, but users with hyperthyroidism, Graves' disease, or thyroid nodules should consult their physician before starting tyrosine supplementation. Users on thyroid hormone replacement (levothyroxine) for hypothyroidism may experience modest changes in thyroid requirements with chronic tyrosine use, though clinically significant effects are uncommon at typical doses. Melanin synthesis effects are a specific consideration for users with melanoma history or risk factors. Tyrosine is the starting material for melanin biosynthesis via the tyrosinase enzyme in melanocytes. Theoretical concerns exist that high-dose chronic tyrosine supplementation could stimulate melanoma cell growth or promote melanin-related pathology in susceptible individuals. The evidence base for this concern is limited — no clinical studies have demonstrated that dietary or supplemental tyrosine promotes melanoma growth in humans — but users with active melanoma, personal history of melanoma, or strong family history of melanoma should avoid high-dose chronic tyrosine supplementation and should consult their oncologist before starting the compound. MAO inhibitor interactions are a more clearly documented and serious safety concern. Tyrosine is a precursor to catecholamines, and MAO inhibitors prevent the breakdown of catecholamines. The combination of tyrosine supplementation with MAO inhibitor therapy could theoretically produce dangerous elevations in catecholamine levels, resulting in hypertensive crisis, cardiac arrhythmias, or other sympathomimetic toxicity. Patients on MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid, moclobemide) or recent MAO inhibitor use (within 2 weeks of discontinuation) should avoid tyrosine supplementation. This interaction is analogous to the classical "tyramine reaction" that MAO inhibitor patients must avoid with aged cheeses, fermented foods, and certain medications. Interactions with L-DOPA in Parkinson's disease: tyrosine and L-DOPA compete for LAT1 transport at the blood-brain barrier, and high-dose tyrosine could theoretically interfere with L-DOPA delivery to the brain. PD patients on L-DOPA therapy should avoid high-dose tyrosine supplementation or take it at different times than L-DOPA doses. Thyroid medication interactions, as noted above, may occur with chronic high-dose use. Interactions with stimulants (amphetamines, methylphenidate, caffeine at high doses) can produce additive catecholaminergic effects including anxiety, insomnia, and cardiovascular activation. Combining tyrosine with prescription stimulants warrants medical awareness. Overdose risk with tyrosine is low. Ingestion of large quantities produces GI symptoms, headache, and possible cardiovascular activation but is not typically life-threatening. LD50 in animals is very high (>5 g/kg). Management of overdose is supportive. Pregnancy and lactation: tyrosine is a normal dietary component and supplemental doses within the typical range (500-2000 mg daily) are not known to cause developmental or lactation concerns. Higher doses have not been extensively studied in pregnancy, and pregnant women should consult their physician before starting tyrosine supplementation. Pediatric use: tyrosine is safely used in children with PKU at medically directed doses. Cognitive-performance supplementation in children without specific indications is not recommended without medical supervision. Overall, tyrosine's side effect profile is favorable and compatible with routine supplementation in healthy adults, with clear cautions for specific medical conditions and medication interactions.
Where can I buy L-Tyrosine?
Visit our vendor directory to find trusted sources for L-Tyrosine.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
